FINGORHYMS - Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis
Phase of Trial: Phase IV
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FINGORHYMS
- 04 Jan 2019 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.
- 04 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.
- 17 Jul 2017 New trial record